Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Target Engagement of Centella Asiatica in Cognitive Impairment

NCT05591027 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT05591027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05591027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
Lead sponsor
Oregon Health and Science University
Phase
Phase 1
Overall status
Recruiting
Start date
December 1, 2022
Completion date
March 31, 2026
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, mild cognitive impairment